Newsquawk Logo

AbbVie (ABBV) announces European Commission approval of AQUIPTA for the acute treatment of migraine in adults

ByNewsquawk Staff
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard
#EUROPE#ABBVIE INC#ABBV.US#EQUITIES#EU SESSION#BIOTECHNOLOGY#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ABBVIE INC#ABBV#GLOBAL NEWS
External
Published: Updated:
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.